标题
Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 13, Pages 9525-9536
出版商
American Chemical Society (ACS)
发表日期
2021-06-25
DOI
10.1021/acs.jmedchem.1c00831
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- A New FXR Ligand Chemotype with Agonist/Antagonist Switch
- (2021) Moritz Helmstädter et al. ACS Medicinal Chemistry Letters
- PTUPB ameliorates high-fat diet-induced non-alcoholic fatty liver disease via inhibiting NLRP3 inflammasome activation in mice
- (2020) Chen-Chen Sun et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- L-thyroxin and the non-classical thyroid hormone TETRAC are potent activators of PPARγ
- (2020) Leonie Gellrich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epoxygenase-derived epoxyeicosatrienoic acid (EET) mediators are associated with NAFLD, NASH and fibrosis
- (2020) Ashwini Arvind et al. GASTROENTEROLOGY
- Multiple Parallel Hits Hypothesis in NAFLD – Revisited After a Decade
- (2020) Herbert Tilg et al. HEPATOLOGY
- FDA rejects NASH drug
- (2020) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype
- (2019) Pascal Heitel et al. ACS Medicinal Chemistry Letters
- A dual farnesoid X receptor/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice
- (2019) Md. Abdul Hye Khan et al. BIOCHEMICAL PHARMACOLOGY
- Epoxyeicosatrienoic acids alleviate methionine‐choline‐deficient diet‐induced non‐alcoholic steatohepatitis in mice
- (2019) Xiaojing Wang et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in HO-1-PGC1α mitochondrial signaling
- (2019) Marco Raffaele et al. EXPERIMENTAL CELL RESEARCH
- Molecular tuning of farnesoid X receptor partial agonism
- (2019) Daniel Merk et al. Nature Communications
- Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats
- (2018) Chi-Hao Zhang et al. Clinics and Research in Hepatology and Gastroenterology
- Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
- (2018) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Optimization of Pranlukast to Farnesoid X Receptor Modulators
- (2018) Simone Schierle et al. ChemMedChem
- A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
- (2017) Jurema Schmidt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nonacidic Farnesoid X Receptor Modulators
- (2017) Daniel Flesch et al. JOURNAL OF MEDICINAL CHEMISTRY
- Palladium-Catalyzed Carbonylative Transformation of Organic Halides with Formic Acid as the Coupling Partner and CO Source: Synthesis of Carboxylic Acids
- (2017) Fu-Peng Wu et al. JOURNAL OF ORGANIC CHEMISTRY
- Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
- (2017) Anna M. Diehl et al. NEW ENGLAND JOURNAL OF MEDICINE
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Pathogenesis of Nonalcoholic Steatohepatitis
- (2016) Mariana Verdelho Machado et al. GASTROENTEROLOGY
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The soluble epoxide hydrolase determines cholesterol homeostasis by regulating AMPK and SREBP activity
- (2016) Nicole Mangels et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Evaluation oftert-Butyl Isosteres: Case Studies of Physicochemical and Pharmacokinetic Properties, Efficacies, and Activities
- (2015) Matthias V. Westphal et al. ChemMedChem
- N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators
- (2015) René Blöcher et al. JOURNAL OF MEDICINAL CHEMISTRY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice
- (2015) Todd R. Harris et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
- (2015) Changtao Jiang et al. Nature Communications
- NSAIDs Ibuprofen, Indometacin and Diclofenac do not interact with Farnesoid X Receptor
- (2015) Jurema Schmidt et al. Scientific Reports
- Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist
- (2014) Daniel Merk et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease
- (2014) Robert N. Schuck et al. PLoS One
- Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates Diet-induced Endoplasmic Reticulum Stress in Liver and Adipose Tissue
- (2013) Ahmed Bettaieb et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metabolically Stable tert-Butyl Replacement
- (2013) David Barnes-Seeman et al. ACS Medicinal Chemistry Letters
- Investigation of imatinib and other approved drugs as starting points for antidiabetic drug discovery with FXR modulating activity
- (2012) Ramona Steri et al. BIOCHEMICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now